Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Profile Name | KDR A1065T |
| Gene Variant Detail | |
| Relevant Treatment Approaches | VEGFR Inhibitor (Pan) VEGFR2 Inhibitor |
| Molecular Profile | Indication/Tumor Type | Response Type | Relevant Treatment Approaches | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|---|---|---|---|---|---|---|---|
| KDR A1065T | Advanced Solid Tumor | sensitive | VEGFR2 Inhibitor | Sunitinib | Preclinical | Actionable | In a preclinical study, cells expressing KDR A1065T were sensitive to Sutent (sunitinib) in culture (PMID: 19723655). | 19723655 |